IP Library › Granted Patent US 9,211,298
Granted Patent B2
US 9,211,298 · App. 14/072,998 · Granted Dec 15, 2015

Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses

Inventor: Song Gao (East Brunswick, NJ)
A61K31/7024A61K31/05A61K31/202A61K31/205A61K31/381A61K36/744A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,211,298
App. No.
14/072,998
Granted
Dec 15, 2015
Kind
B2
Abstract

The invention relates to unique compositions containing enriched and purified natural crocin and/or crocetin for prevention and/or treatment of cancers and other conditions and diseases. Compositions comprise mainly enriched or purified natural crocin or crocetin or combination of both and possible other active phytochemicals. A composition is used as functional food, drink, dietary supplement, or therapeutic dosage to a human orally or through other appropriate way (parenteral, percutaneous, rectal, mucosal, intranasal or topical administration). A method of natural crocin and crocetin enriching and purification is revealed.

Claims (10)

1. A nutraceutical or therapeutic composition, comprising, in percentage by weight, 1 -60 % of crocin or crocetin or both, 1 -50 % of green tea extract, 1 -40 % of curcumin, 1 -40 % of resveratrol, 1 -40 % of Panax ginseng extract, 0.5 -20 % of a-lipoic acid, and 0.1 -20 % of L-carnitine, wherein crocin and/or crocetin is extracted, enriched and/or purified from natural source.

2. The composition according to claim 1 , wherein the composition is formed as tablets, soft gels, capsules, pills, caplets, dragees, granules, powders, or effervescent tablets, liquid, sprays, functional foods, gums, chewing gum, gummi candy, taffy, caramel candy, fudge, degradable thin films, nondegradable thin films, hard candy, liquids, drinks, or beverages.

3. The composition according to claim 1 , wherein the composition is an immediate release composition, a mixed-release composition, or an enterically-coated composition.

4. The composition according to claim 3 , wherein the mixed-release composition is a bilayer tablet.

5. A method of mitigating or treating Alzheimer's disease or Parkinson's disease in a subject, said method comprising administering an effective amount of the composition according to claim 1 to the subject in need thereof.

6. The method according to claim 5 , wherein said subject is a mammal.

7. The method according to claim 6 , wherein said subject is a human.

8. The method according to claim 5 , said administering is done through at least one of the following: orally, transmucosally, buccally, percutaneously.

9. The method according to claim 5 , wherein said composition improves/enhances brain function, healthy aging and/or mental health.

10. The method according to claim 5 , wherein said composition improves/enhances learning, memory and/or cognitive abilities.

Continuity (2)
Provisional Application 61727244 · Nov 16, 2012
Related Publication 20140141082A1 · May 22, 2014